NCT02150369
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +25 more
- Locations
-
- Duke University Hospital Durham, North Carolina, United States
Clinical trial condition
High-dose Interleukin-2
Explore clinical trials studying High-dose Interleukin-2. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies